The share price of Zynerba Pharmaceuticals Inc. Get a real-time Zynerba Pharmaceuticals ZYNE stock price quote with breaking news financials statistics charts and more.
Wall Street Stock Market Finance report prediction for the future.
Zynerba pharmaceuticals stock forecast. GW Pharma shares surge 27 after Zynerba Pharmas failed cannabidiol gel trial Aug. Negative monthly dynamics of the instrument is expected with 12233 volatility is expected. View ZYNEs stock price price target earnings financials forecast insider trades news and SEC filings at MarketBeat.
As of 2021 May 15 Saturday. How much will Zynerba stock be worth in 2023. Exploring Zynerba Pharmaceuticals NASDAQZYNE stock.
252 rows Zynerba Pharmaceuticals Inc Stock Price Forecast ZYNE Predictons for2021. The average price target is 825 with a high forecast of 900 and a low forecast of 725The average price target represents a 9458 increase from the last price of 424. Zynerba stock price predictions for 2023 using artificial intelligence.
NASDAQZYNE Research analysts at Jefferies Financial Group boosted their Q2 2021 earnings per share EPS estimates for shares of Zynerba Pharmaceuticals in a note issued to investors on Wednesday May 12th. Estimated Average Forecasted Zynerba Price. Zynerba stock price predictions for 2026 using artificial intelligence.
Zynerba stock forecast for 16052021. Zynerba Pharmaceuticals has not formally confirmed its next earnings publication date but the companys estimated earnings date is Monday May 10th 2021 based off prior years report dates. The Zynerba Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
The share price of Zynerba Pharmaceuticals Inc. Zynerba ZYNE stock forecast for 2023. Tsai now anticipates that the company will post earnings of 019 per share for the.
Also there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. See Zynerba Pharmaceuticals Inc. All times are ET.
Zynerba ZYNE stock forecast for 2026. How much will Zynerba stock be worth in 2026. However the stock was trading lower by 16 percent in pre-market trading on March 16.
Zynerba Pharmaceuticals Inc Stock Market info Recommendations. ZYNERBA PHARMACEUTICALS INC stock price forecast for further price development down to -357 time horizon. 442 Zynerba stock forecast for 17052021.
Jefferies Financial Group analyst A. The average Zynerba Pharmaceuticals stock price prediction forecasts a potential downside of NA from the current ZYNE share price of 446. 7 2017 at 938 am.
Zynerba stock forecast for Jan 2024. According to 7 analysts the average rating for ZYNE stock is Buy. Zynerba Pharmaceuticals stock gained 49 percent on March 15.
Get a real-time Zynerba Pharmaceuticals ZYNE stock price quote with breaking news financials statistics charts and more. Zynerba Pharmaceuticals has generated 150 earnings per share over the last year. 1 day and price target of 425 USD.
Market indices are shown in real time except for the DJIA which is delayed by two minutes. Whats the forecast for ZYNE stock in. Zynerba Pharmaceuticalss share price could stay at 2400 by Jul 1 2021.
2 weeks ZYNERBA PHARMACEUTICALS INC share price prediction for 2021-05-14 with daily closed price projections. 9 312. Most stock quote data provided by BATS.
Youll find the Zynerba Pharmaceuticals share forecasts stock quote and buy sell signals belowAccording to present data Zynerba Pharmaceuticalss ZYNE shares and potentially its market environment have. Zynerba Pharmaceuticals Inc. Estimated Average Forecasted Zynerba Price.
Zynerba Pharmaceuticals Earnings Estimates and Actuals by Quarter. ET by Emma Court Zynerbas stock on track to open at lowest level since June 2016. Based on 6 analysts offering 12 month price targets for Zynerba Pharmaceuticals in the last 3 months.
ZYNE stock analyst estimates including earnings and revenue EPS upgrades and downgrades. 537 Zynerba stock forecast for Feb 2024. On average Wall Street analysts predict that.
434 Positive intraday dynamics of the instrument is expected with 6252 volatility is expected. Buy or sell Zynerba Pharmaceuticals stock. 130 rows About the Zynerba Pharmaceuticals Inc.
